Telehealth General Psychiatry Prescribing: What Psychiatric NPs Can Do in California

If you’re a psychiatrist or psychiatric nurse practitioner wondering whether you can prescribe medications through telehealth — especially controlled substances like Adderall, Xanax, or antidepressants — you’re asking the right question. The short answer: Yes, psychiatrists can prescribe virtually all psychiatric medications via telehealth in 2026, including Schedule II stimulants and benzodiazepines, thanks to extended federal flexibilities and state-level support for telepsychiatry.

But the reality is more nuanced. Your prescribing authority depends on your credential (MD/DO vs PMHNP), the state where your patient is located, and evolving federal rules around controlled substances. This guide breaks down exactly what psychiatrists and psychiatric prescribers can do via telehealth, how scope of practice differs by state, and what you need to know to stay compliant while building a thriving telemedicine practice.

The Current State of Telehealth Prescribing for Psychiatrists

Federal Rules: DEA Flexibilities Extended Through 2025

The big concern for psychiatric prescribers has always been the Ryan Haight Act, which federally required an in-person medical evaluation before prescribing controlled substances. During COVID-19, the DEA waived this requirement under public health emergency powers — and critically, those telehealth flexibilities remain in effect through December 31, 2025 and are likely to be extended further.

What does this mean practically? As of early 2026, psychiatrists can:

• Initiate controlled substance prescriptions via video visit for new patients without an in-person exam
• Prescribe Schedule II–V medications (stimulants for ADHD, benzodiazepines for anxiety, buprenorphine for opioid use disorder) entirely through telemedicine
• Continue ongoing medication management remotely for established patients

This applies nationwide. A psychiatrist licensed in Texas can start a new patient on Adderall for ADHD via telehealth. A New York psychiatrist can prescribe Klonopin for panic disorder after a video evaluation. Florida psychiatrists can manage antidepressants and mood stabilizers completely online.

The caveat: The DEA has proposed new rules that could reinstate some in-person requirements or impose a 30-day supply limit for initial controlled substance prescriptions via telehealth. These rules are under review and haven’t been finalized as of February 2026. Psychiatrists should monitor DEA announcements, but for now, the flexible environment continues.

State-Level Telehealth Prescribing: Mental Health Gets Special Treatment

While federal law sets the baseline, states add their own rules. The good news: most states explicitly support telepsychiatry and psychiatric prescribing. Mental health has been carved out for favorable telehealth treatment in many state laws, recognizing the accessibility crisis.

Some examples:

• Florida explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (Florida Statute 456.47), while prohibiting it for chronic pain management
• Texas permits telemedicine prescribing as long as a proper audio-visual evaluation is conducted, with an exception against teleprescribing Schedule II opioids for chronic pain (but ADHD stimulants and psych meds are allowed)
• California requires a ‘good faith exam’ before prescribing, but telehealth video visits satisfy this requirement — no in-person visit needed
• New York recently finalized regulations aligning state law with federal DEA waivers, explicitly permitting controlled substance prescribing via telemedicine when federal law allows it
• Pennsylvania and Illinois follow federal telehealth guidelines without additional state barriers for psychiatric medication management

The pattern: states recognize that forcing in-person visits for psychiatric medication management would decimate access, especially in underserved areas. Telehealth parity laws in 40+ states now require insurers to reimburse telepsychiatry at the same rate as in-person visits — a huge win for provider economics.

Free consultations available with select providers only.

Grow your practice on Klarity

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

Start seeing patients

Free to list. Pay only for new patient bookings. Most providers see their first patient within 24 hours.

What Psychiatrists Can Prescribe via Telehealth (and What PMHNPs Face)

Psychiatrists (MD/DO): Full Prescribing Authority Everywhere

If you’re a board-certified psychiatrist with a medical license and DEA registration, your prescribing authority via telehealth is essentially unlimited within your scope of practice:

• All antidepressants, antipsychotics, mood stabilizers (non-controlled)
• Benzodiazepines (Schedule IV) for anxiety, insomnia
• Stimulants (Schedule II) like Adderall, Vyvanse, Ritalin for ADHD
• Buprenorphine (Schedule III) for opioid use disorder
• Any psychiatric medication indicated for your patient’s condition

You must be licensed in the state where the patient is physically located during the visit. If you’re seeing patients across multiple states, you need licenses in each (though the Interstate Medical Licensure Compact can expedite this for member states like Texas, Pennsylvania, and Illinois).

Key compliance requirements:

• Conduct a thorough telehealth evaluation (video, not just phone, for initial controlled substance prescriptions)
• Check your state’s prescription drug monitoring program (PDMP) before prescribing Schedule II–IV medications (required in Texas, California, New York, Florida, Pennsylvania, Illinois)
• Document the visit thoroughly — note that it was telehealth, patient location, consent obtained
• Follow state-specific telehealth rules (e.g., Texas requires a defined emergency plan; California requires CURES database enrollment)

There are virtually no psychiatric medications a psychiatrist can’t prescribe via telehealth under current rules. Clozapine requires REMS enrollment (same as in-person). Some states have special requirements for MAOIs or high-dose prescribing, but those apply equally to telehealth and office visits.

Psychiatric Nurse Practitioners: It Depends Entirely on Your State

If you’re a PMHNP, your prescribing authority via telehealth mirrors your in-person authority — which varies dramatically by state. This is where the complexity lives.

Full Practice Authority States (about 34 states as of 2026): PMHNPs can practice and prescribe independently, including controlled substances, with no physician oversight. Examples include Washington, Oregon, Colorado, Arizona, Montana, Alaska, and recently added states like Massachusetts, Kansas, Indiana, Louisiana, and Michigan.

In these states, a PMHNP operates like a psychiatrist — own DEA number, independent evaluation and prescribing, full telehealth access. You can start a patient on Adderall, adjust antidepressants, prescribe benzodiazepines, all via video visit, with no physician co-signature required.

Reduced Practice States (transition-to-independence model): States like New York and Illinois require initial physician collaboration but grant independence after experience:

• New York: PMHNPs need 3,600 hours (≈2 years) of practice under a collaborative agreement, then can practice fully independently including telehealth prescribing
• Illinois: PMHNPs need 4,000 hours of collaboration + 250 hours of continuing education, then apply for Full Practice Authority and prescribe independently
• California: Transitioning via AB 890 — experienced NPs (≥3 years) can practice without supervision in group settings as of 2023, and by January 2026 can apply for full independent practice (104 NP certification)

During the collaboration phase in these states, your prescribing is technically under physician delegation. In Illinois, for instance, your prescriptions must list your collaborating physician. In New York, you follow written protocols during the first 3,600 hours. But the endpoint is independence.

Restricted Practice States (ongoing physician supervision required): Texas, Florida, and Pennsylvania fall into this category for PMHNPs, creating the biggest barriers:

• Texas: PMHNPs cannot prescribe independently, ever. You must have a Prescriptive Authority Agreement with a Texas-licensed physician. Texas also restricts NP prescribing of Schedule II controlled substances in outpatient settings — practically, Texas PMHNPs often can’t initiate stimulants (the collaborating physician must write the initial script). You need regular face-to-face meetings with your collaborating physician (monthly for first 3 years, then quarterly). One physician can supervise max 7 NPs.

• Florida: PMHNPs are excluded from the state’s ‘autonomous APRN’ law (which only applies to primary care NPs). Psychiatric NPs must practice under a supervising physician’s protocol. However, Florida does allow ‘psychiatric nurses’ (PMHNPs with ≥2 years experience under a psychiatrist) to prescribe psychotropic controlled substances in collaboration with a psychiatrist, and they’re exempt from the 7-day Schedule II limit that applies to other NPs. You can prescribe ADHD meds and anxiety meds via telehealth in Florida, but you need a psychiatrist collaborator on paper.

• Pennsylvania: PMHNPs must maintain a collaborative agreement indefinitely (no path to independence yet). The agreement must specify your prescriptive authority. You can prescribe Schedule II medications, but limited to 30-day supply initially and must notify the collaborating physician within 24 hours. Chart co-signing is required (often 10% of charts).

Bottom line for PMHNPs: In full practice authority states, you’re essentially equal to a psychiatrist for telehealth prescribing. In restricted states, you’re working under physician oversight, which adds administrative burden and can limit your autonomy — but telehealth is still possible with the right practice structure.

State-by-State Breakdown: Where You Can Prescribe What

Because prescribing laws differ so much by state, here’s what you need to know for the six key markets where psychiatric demand is highest:

California

Psychiatrists: Full independent prescribing via telehealth. California requires a ‘good faith exam’ before prescribing, but explicitly accepts video visits. No in-person requirement. You must check California’s CURES database (PDMP) before prescribing Schedule II–IV medications.

PMHNPs: Transitioning to independence. New NPs work under physician-supervised ‘standardized procedures’ for first 3 years. After 3 years of experience, you can become a ‘103 NP’ (practice without direct supervision in group settings). By January 2026, you can apply for ‘104 NP’ status and practice fully independently, including telehealth prescribing of controlled substances.

Market opportunity: California has 11+ million residents in mental health professional shortage areas despite having relatively better psychiatrist density than most states (1:5,339). Telehealth demand is massive, especially in Central Valley and rural Northern California. Medi-Cal and private insurers pay telehealth at parity.

Texas

Psychiatrists: Full prescribing authority via telehealth. Texas law requires a proper ‘telemedicine medical service’ (real-time audio-visual) to establish patient relationship before prescribing. You can prescribe psychiatric medications including controlled substances remotely, but Texas prohibits teleprescribing Schedule II opioids for chronic pain (doesn’t affect psychiatric practice). Must check Texas PMP before any controlled substance prescription.

PMHNPs: Restricted. Must have Prescriptive Authority Agreement with a Texas physician to prescribe anything. Schedule II controlled substances (ADHD stimulants) generally cannot be prescribed by NPs in outpatient settings — the collaborating physician must write those scripts. Schedule III–V (like Suboxone, some sedatives) can be prescribed under delegation. Monthly meetings required for first 3 years of agreement, then quarterly.

Market reality: Texas has one of the worst psychiatrist shortages in the nation (1:8,500+ residents, 614 psychiatrists needed to eliminate HPSAs). The NP restrictions create bottlenecks — psychiatrists are in extremely high demand. Telehealth is a lifeline, but PMHNPs face structural barriers.

Revenue note: Texas has no telehealth payment parity law, but major insurers voluntarily reimburse tele-mental health at in-person rates due to demand.

Florida

Psychiatrists: Full telehealth prescribing. Florida is uniquely permissive — state law explicitly allows controlled substance prescribing via telehealth for psychiatric treatment (FS 456.47). This is a carved-out exception; chronic pain management via telehealth still requires in-person visits. Psychiatrists can initiate and manage ADHD, anxiety, depression medications entirely online.

PMHNPs: Must practice under physician supervision. Florida’s autonomous APRN law excludes psychiatric NPs. However, ‘psychiatric nurses’ (PMHNPs with ≥2 years psych experience under a psychiatrist) can prescribe psychotropic controlled substances for mental health in collaboration with a psychiatrist, and they’re exempt from the 7-day Schedule II limit. So you can prescribe stimulants and benzos via telehealth as a PMHNP in Florida, but you need a collaborating psychiatrist.

Market: Florida has ~7.8 million people in mental health shortage areas, 1:9,000+ psychiatrist ratio. Huge elderly population (Medicare patients) and growing telehealth adoption. Strong commercial insurance presence.

New York

Psychiatrists: Full prescribing via telehealth. New York recently finalized rules aligning state law with DEA waivers — controlled substances can be prescribed via telemedicine when federal law allows it. You must check New York’s I-STOP PMP database before prescribing Schedule II–IV. E-prescribing is mandatory (no paper scripts).

PMHNPs: Initially restricted, then independent. New NPs must practice under a collaborative agreement with written protocols for first 3,600 hours (≈2 years). After that, you can practice independently — no physician oversight required for prescribing. You attest to having a ‘collaborative relationship’ (informal physician contacts for referrals), but no supervision or chart review. Experienced NY PMHNPs have full telehealth prescribing authority.

Market: New York has good psychiatrist density in NYC (1:2,900 statewide) but severe shortages upstate (197 shortage areas needing 230+ psychiatrists). Telehealth with payment parity is permanently established. Strong Medicaid and commercial insurance coverage.

Pennsylvania

Psychiatrists: Full telehealth prescribing, no state-level restrictions beyond federal DEA rules. Must follow standard of care for evaluation.

PMHNPs: Must have collaborative agreement indefinitely. No independent practice pathway yet (legislation pending). You can prescribe Schedule II–V under physician delegation, but Schedule II prescriptions are limited to 30-day supply initially and require physician notification within 24 hours. Physician must co-sign charts regularly (often 10% minimum). Collaboration agreement must be filed with PA Board of Nursing.

Market: Pennsylvania has ~2,800 psychiatrists for 13 million people (1:4,586 ratio), with 65 psychiatrist vacancies to eliminate HPSAs. Rural central PA is underserved. Medicaid and insurers cover telepsychiatry but no comprehensive parity statute yet (efforts ongoing).

Illinois

Psychiatrists: Full prescribing via telehealth, no restrictions.

PMHNPs: Must collaborate for first 4,000 hours + complete 250 hours of continuing education in pharmacology, then can apply for Full Practice Authority. Once you have FPA, you prescribe independently including controlled substances (must get your own mid-level controlled substance registration). Until FPA, prescriptions must list collaborating physician’s name.

Market: Illinois has ~291 practitioners needed to fill mental health gaps. Chicago has decent access; rural southern Illinois is severely underserved. State has strong telehealth parity law (equal reimbursement through 2027). Illinois also uniquely allows specially trained clinical psychologists to prescribe limited mental health medications under psychiatrist supervision — adds to prescriber pool.

Reimbursement: What Telehealth Psychiatric Prescribing Pays

Understanding reimbursement is critical for practice viability. The good news: telehealth psychiatric medication management pays well and has payment parity in most states.

Medicare Rates (2026 National Average)

Psychiatrists bill medication management visits using standard E/M codes:

• CPT 90792 (initial psychiatric evaluation with medication services, ~60 min): ~$173
• CPT 99213 (15-minute med check follow-up): ~$95
• CPT 99214 (25-minute med check, moderate complexity): ~$136
• CPT 99215 (40-minute complex visit): ~$192

If you combine brief therapy with medication management in the same visit, you can add psychotherapy codes (e.g., 99213 + 90833 for a 20-min med check + 20-min therapy session adds ~$80).

Medicare pays PMHNPs at 85% of physician rates when billed under the NP’s NPI. So a PMHNP would get ~$81 for a 99213 and ~$116 for a 99214 from Medicare.

Medicare has permanently extended telehealth coverage for mental health services with minimal restrictions (they’ve proposed requiring one in-person visit every 12 months for ongoing patients, but this is paused through 2025). You bill the same codes for video visits using place of service code 02 or modifier -95.

Private Insurance

Commercial payers typically reimburse at 120–200% of Medicare rates depending on market and contract. A well-negotiated contract in a high-demand area might pay:

• $150–$180 for a 15-minute med check (99213)
• $200–$250 for a 25-minute visit (99214)

Telehealth parity laws in 43+ states require private insurers to cover telehealth at the same rate as in-person. States with strong parity include:

• California (AB 744 — mandatory parity since 2021)
• Illinois (equal reimbursement through 2027)
• New York (permanent parity for mental health)
• Connecticut, Massachusetts, Georgia (permanent parity laws)

Some insurers tried to reduce telehealth payments post-pandemic, but legislative and public pressure — especially for behavioral health — has kept rates equal in most markets.

Medicaid

Medicaid rates are lower but patient volume is often higher. Typical state Medicaid rates for a psychiatric med check range from $60–$90. However, many state Medicaid programs have enhanced mental health payments or pay for collaborative care management (monthly per-patient fees for psychiatric consultation to primary care).

Most state Medicaid programs reimburse telehealth at parity now:

• New York Medicaid: full parity since before pandemic
• California Medi-Cal: parity for tele-mental health (and recent rate increases)
• Texas Medicaid: covers telepsychiatry (no parity mandate but rates consistent)
• Illinois Medicaid: parity for behavioral health telehealth

Medicaid also reimburses audio-only telehealth for mental health in many states (phone visits) — important for patients without reliable video access. Medicare also pays for audio-only mental health services through at least 2025.

Cash Pay and Self-Pay Models

Many telepsychiatry providers opt for cash-based models to avoid insurance overhead. Typical cash rates for medication management visits:

• Initial evaluation: $200–$400
• Follow-up med checks: $100–$200

Platforms that handle patient acquisition and telehealth infrastructure (like Klarity Health) often use a pay-per-appointment model where providers pay a standard fee per booked patient rather than monthly marketing spend. This shifts acquisition risk off the provider — you only pay when a qualified patient actually shows up, not for advertising clicks that don’t convert.

The Economics of Building a Telehealth Psychiatry Practice

Let’s talk real numbers. If you’re considering telehealth psychiatric prescribing, you need to understand patient acquisition costs and revenue potential.

The DIY Marketing Trap

Many psychiatrists assume they can acquire patients cheaply through DIY marketing — Google Ads, Psychology Today listings, SEO. Reality check:

• Google Ads for psychiatric keywords cost $15–$40+ per click. Most clicks don’t convert to booked patients. A realistic cost per booked patient through PPC is $200–$400+ after you factor in:

• Ad spend testing and optimization (months of trial and error)

• Agency or consultant fees if you don’t run ads yourself

• Staff time to handle and qualify leads

• No-show rates from cold leads (often 20–30%)

• SEO takes 6–12 months of consistent investment (content creation, website optimization, backlink building) before generating meaningful patient flow. Few solo providers have the expertise or patience.

• Directory listings (Psychology Today, Zocdoc) charge monthly fees AND you compete with hundreds of other providers on the same page. Zocdoc charges per booking ($35–$100+ per patient) plus subscription fees. Total monthly cost for directories + ads + website easily hits $3,000–$5,000 with uncertain results.

Total patient acquisition cost through DIY channels: realistically $200–$500+ per patient when you factor in ALL costs — wasted ad spend, failed campaigns, staff time, months of upfront investment before results.

DIY marketing can eventually be cost-effective IF you have the budget, expertise, and patience. But for most providers — especially those starting out or scaling — it’s a gamble.

The Platform Model: Klarity Health’s Approach

Klarity Health uses a pay-per-appointment model similar to Zocdoc but optimized for psychiatric providers:

• No upfront marketing spend or monthly subscription fees
• Pay only when a qualified patient books with you (standard listing fee per new patient lead)
• Pre-qualified patients already matched to your specialty and availability
• No wasted ad spend on clicks that don’t convert
• Built-in telehealth infrastructure (no separate platform costs)
• Both insurance and cash-pay patient flow
• You control your schedule — only accept patients when you have availability

The economic case: Instead of spending $3,000–$5,000/month on marketing with uncertain ROI, you pay a known, predictable fee per booked appointment. Every dollar you spend results in a patient in your schedule. That’s guaranteed ROI vs gambling on marketing channels.

For a psychiatrist billing insurance at $150 per med check visit, if you see a patient 4 times per year (quarterly med management), lifetime value is $600. If Klarity’s per-appointment fee is, say, $100–$150 (a standard industry rate), you’re profitable from the first few visits.

For PMHNPs billing at 85% of physician rates, the math still works — your per-visit revenue might be $120–$130, patient sees you 4–6 times per year ($480–$780 LTV), and you’re still ahead after the acquisition fee.

Volume and Scheduling Flexibility

Telehealth lets you control volume and schedule:

• See 4 patients per hour (15-min med checks) = $380–$600 per hour gross (insurance rates)
• See 20 patients per week = $7,600–$12,000 per week gross
• Annual potential: $380K–$600K+ gross revenue before overhead

If you’re using a platform like Klarity for patient acquisition, your overhead is essentially:

• Platform fee per patient (paid as you go)
• Malpractice insurance (telehealth-specific, often $5K–$10K/year)
• State licenses (if practicing in multiple states, $500–$2,000 per state)
• DEA registration ($888 every 3 years federal, some states charge extra)
• Minimal tech costs (laptop, secure internet, optional EHR if platform doesn’t provide)

No office rent, no staff salaries, no physical overhead. This is why telehealth psychiatric prescribing is one of the highest-margin medical practices available.

Controlled Substances and PDMP Compliance

A critical operational detail: every state requires checking the Prescription Drug Monitoring Program (PDMP) before prescribing controlled substances. This applies equally to telehealth.

State PDMP Requirements

• Texas: Check Texas PMP before every controlled substance prescription (mandatory)
• California: Check CURES database before prescribing Schedule II–IV; must check at least once every 4 months for ongoing patients
• New York: Check I-STOP registry before prescribing Schedule II–IV (mandatory)
• Florida: Check E-FORCSE database before prescribing Schedule II–IV
• Pennsylvania: Check PDMP before prescribing Schedule II (recommended, will be mandatory)
• Illinois: Check PMP before prescribing controlled substances

Most PMDPs are now integrated with EHR systems, making checks faster. You’re looking for red flags: multiple prescribers, early refills, overlapping opioid/benzo prescriptions.

Telehealth consideration: Document that you checked the PDMP in your visit note. Some state audits specifically look for this in telehealth controlled substance prescriptions.

E-Prescribing Requirements

Many states mandate electronic prescribing for controlled substances (EPCS):

• New York: Mandatory e-prescribing, no paper scripts for controlled meds (since 2016)
• California: Mandatory EPCS for controlled substances (exceptions for system downtime)
• Minnesota, Maine, and others have similar rules

You’ll need an EPCS-enabled platform that uses two-factor authentication for controlled substance prescriptions. Most telehealth EHRs (including Klarity’s built-in system) support this.

Future Outlook: What’s Coming for Psychiatric Prescribing

DEA Rule Changes (Watch for 2026–2027)

The DEA’s temporary telehealth waivers are currently extended through December 31, 2025. The DEA proposed new permanent rules in 2023 that would:

• Allow a 30-day supply of controlled substances to be prescribed via telehealth without an in-person visit (for new patients)
• Require in-person evaluation for ongoing prescriptions OR if patient was referred by another provider who saw them in-person within 12 months
• Create a special telehealth DEA registration for providers exclusively practicing online

These rules have not been finalized. Strong opposition from mental health advocacy groups, medical associations, and members of Congress highlighted that reimposing in-person requirements would devastate access to ADHD treatment, buprenorphine for opioid use disorder, and anxiety management in underserved areas.

Most analysts expect either:

• Another extension of current flexibilities through 2026–2027
• A mental health carve-out allowing continued telehealth prescribing for psychiatric conditions
• Implementation of the 30-day rule with broad exceptions

What you should do: Monitor DEA announcements. Join your state medical or psychiatric association to stay informed. Have a plan for how you’d handle an in-person requirement if it materializes (partner with local clinics, require annual in-person visits, etc.). But don’t let fear of potential future changes stop you from building a telehealth practice now — the political and clinical momentum is behind preserving psychiatric telehealth access.

State Scope of Practice Expansions

The trend is clearly toward expanding NP independence. Since 2020, over a dozen states have moved to full practice authority for NPs. States to watch:

• Pennsylvania: Full practice authority legislation has strong support; could pass in 2026–2027
• Florida: Ongoing efforts to include psychiatric NPs in autonomous practice law
• Texas: More resistant, but workforce shortages may eventually force legislative change

If you’re a PMHNP in a restricted state, this trend is in your favor. Every year, more states recognize that requiring physician oversight for experienced NPs doesn’t improve patient safety (research consistently shows equivalent outcomes) and severely limits access in shortage areas.

Parity and Reimbursement

Telehealth payment parity for mental health is here to stay. Medicare has made it permanent with minimal restrictions. Most states with temporary COVID-era parity laws have extended them permanently or through at least 2027–2028.

The business case for insurers: Covering telepsychiatry reduces ER visits, improves medication adherence, and prevents costly psychiatric hospitalizations. The ROI is clear, which is why payers aren’t fighting it.

Why This Matters for Your Practice

If you’re a psychiatrist or PMHNP considering telehealth, the regulatory environment in 2026 is more favorable than it’s ever been:

• You can prescribe essentially all psychiatric medications remotely, including controlled substances
• You’ll be paid the same as in-person visits (often more after accounting for no-show rates and overhead savings)
• Patient demand is massive and growing — 120+ million Americans live in mental health shortage areas
• The administrative barriers are falling (multistate licensing compacts, parity laws, scope of practice expansions)

The remaining barriers are:

• State-by-state licensing (though compacts help)
• NP scope of practice restrictions in some states (but improving)
• Potential future federal rule changes (unlikely to be severe for psychiatry)

How Klarity Health Solves the Patient Acquisition Problem

Here’s the reality most providers face: even with favorable prescribing rules and good reimbursement, finding qualified patients consistently is the hardest part of building a telehealth practice.

Klarity Health was built specifically for psychiatric prescribers. Instead of you spending thousands per month on marketing with uncertain results, Klarity handles patient acquisition and matches qualified patients to your schedule.

How it works:

1. You set your availability and patient criteria (insurance vs cash, age ranges, conditions you treat)
2. Klarity’s platform matches you with patients actively seeking psychiatric medication management
3. You pay a standard fee per booked appointment (not per click, not monthly subscription — only when a patient is in your schedule)
4. Built-in telehealth infrastructure handles video visits, documentation, e-prescribing
5. You control your schedule — accept as many or as few patients as you want

The economic advantage: You eliminate the risk of marketing spend with no results. Every dollar you invest results in a patient. Your patient acquisition cost is predictable and manageable. You can scale up or down based on your availability without being locked into monthly contracts.

For psychiatrists: Build a high-margin practice seeing 15–25 patients per week remotely, earning $300K–$600K+ annually with minimal overhead.

For PMHNPs: Start building your patient panel without needing to find a collaborating physician first (in FPA states) or leverage Klarity’s network to connect with supervising psychiatrists (in restricted states). Earn $150K–$300K+ annually with flexibility and autonomy.

Next steps: If you’re licensed (or working toward licensure) in California, Texas, Florida, New York, Pennsylvania, or Illinois, and you’re board-certified in psychiatry or a PMHNP, explore joining Klarity’s provider network. You’ll get immediate access to qualified patients actively seeking medication management, with none of the patient acquisition risk of traditional practice.

The bottom line: The regulatory environment for telehealth psychiatric prescribing is favorable and stable. The patient demand is enormous and growing. The reimbursement is strong with payment parity. The only variable is how you acquire patients — and platforms like Klarity solve that problem by making patient acquisition predictable, affordable, and risk-free.

The future of psychiatric care is telehealth. The question isn’t whether you should be part of it — it’s how quickly you can get started and start making an impact on the millions of patients who need access to psychiatric medication management.

Frequently Asked Questions

Can psychiatrists prescribe Adderall and other stimulants via telehealth?

Yes. As of February 2026, psychiatrists can prescribe Schedule II stimulants (Adderall, Vyvanse, Ritalin, Concerta) via telehealth to new patients without an in-person visit, thanks to extended DEA waivers. This applies in all states, though you must conduct a proper video evaluation and check your state’s PDMP. The DEA may implement new rules in late 2026 that could require an in-person visit for ongoing prescriptions or limit initial telehealth prescriptions to 30 days, but mental health exceptions are likely.

Do I need to see a patient in-person before prescribing antidepressants or antipsychotics?

No. Non-controlled psychiatric medications (SSRIs, SNRIs, antipsychotics, mood stabilizers) have never required in-person visits. You can initiate and manage these medications entirely through telehealth as long as you conduct a thorough video evaluation that meets the standard of care. This applies to both psychiatrists and PMHNPs (within their scope of practice).

Can PMHNPs prescribe controlled substances via telehealth?

It depends on your state. In full practice authority states (34+ states including Washington, Oregon, Colorado, Arizona, Massachusetts, Kansas, New York after 3,600 hours, Illinois after 4,000 hours), PMHNPs can prescribe controlled substances via telehealth independently just like psychiatrists. In restricted states (Texas, Florida, Pennsylvania), you must work under physician supervision and follow your state’s specific rules — Texas prohibits NP prescribing of Schedule II in outpatient settings, Florida allows it for psychiatric nurses with psychiatrist collaboration, Pennsylvania allows it with collaborative agreement and 30-day limits.

What states have the best telehealth prescribing rules for psychiatrists?

For psychiatrists, all states allow full telehealth prescribing — there’s no ‘better’ state from a scope perspective. However, Florida has uniquely permissive language explicitly allowing controlled substance prescribing for psychiatric treatment via telehealth. New York and California have strong telehealth parity laws ensuring equal reimbursement. Texas and Pennsylvania have fewer regulatory barriers (no extra telehealth registration requirements). For PMHNPs, the best states are full practice authority states where you don’t need physician oversight.

Do I need a separate DEA registration for each state where I prescribe?

No. Your DEA registration is federal and applies to all states where you hold a medical license. However, some states require you to register your DEA number with the state pharmacy board or controlled substance authority. For example, California requires DEA registrants to also register with the state to prescribe controlled substances. Check each state’s requirements when obtaining licensure.

How do I check the prescription drug monitoring program (PDMP) in multiple states?

Most states have integrated PDMP databases accessible online after you register. Many EHR systems now have direct PDMP integration, allowing you to check a patient’s prescription history directly from your documentation system. Some states participate in interstate data sharing (PMPi), making it easier to check patients’ prescription history across state lines. You must register for PDMP access in each state where you prescribe controlled substances.

**What if the DEA changes the rules in

Source:

• https://www.bon.texas.gov/faqpracticeaprn.asp.html#:~:text=certificate%20or%20fetal%20death%20certificate,For%20additional%20information
• https://www.npschools.com/blog/guide-to-np-practice-in-florida#:~:text=match%20at%20L200%20%E2%80%9CUnder%20HB,%E2%80%9D
• https://natlawreview.com/article/telehealth-and-person-visits-tracking-federal-and-state-updates-pandemic-era#:~:text=In%20late%202024%2C%20the%20U,prescribing
• https://www.flsenate.gov/laws/statutes/2024/464.012#:~:text=,the%20treatment%20of%20mental%20disorders
• https://www.cchpca.org/texas/#:~:text=including%2C%20but%20not%20limited%20to%2C,Code%2C%20Chapters%20481%20and%20483
• https://www.cchpca.org/texas/#:~:text=,way%20communication
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=As%20of%202025%2C%20the%20distribution,toward%20greater%20autonomy%20for%20NPs
• https://www.nursepractitioneronline.com/articles/nurse-practitioner-practice-authority-updates/#:~:text=,Michigan%20%282025
• https://www.pacnp.org/general/custom.asp?page=ScopeofPractice#:~:text=tests%2C%20and%20deliver%20other%20health,appropriate%20experience%20can%20receive%20a
• https://www.jdsupra.com/legalnews/new-law-allows-experienced-nps-to-8292796/#:~:text=New%20York%E2%80%99s%202023%20state%20budget%2C,practice%20without%20a%20collaborative%20relationship